|
|
Allakos Inc (NASDAQ: ALLK) |
|
*Market share is calculated based on total revenue.
News about Allakos Inc Contracts |
October 10, 2024
Allakos Reports Promising Phase 1 Results for Subcutaneous AK006: A Breakthrough in Allergy Therapy In a significant advancement for the treatment of mast cell-related diseases, Allakos Inc. has announced the successful results of its Phase 1 clinical trial assessing the bioavailability and safety of subcutaneously administered AK006 in healthy volunteers. This novel therapeutic candidate targets mast cell activation and has shown considerable promise, setting the stage for its potential application in treating chronic spontaneous urticaria (CSU).The study revealed that AK006 administered via subcutaneous injection exhibited approximately 77% bioavailability, indicating a robust absorption and subsequent eff...
|
Publicly Traded Peers of Allakos Inc
Vaccinex Inc
Share Performance
-11.00%
This Year
|
Vaccinex Inc
Profile
Vaccinex Inc operates on a biopharmaceutical business model, focusing on the development and commercialization of antibody-based therapies. The company utilizes its proprietary ActivMAb? Antibody Discovery Technology to discover and develop novel antibody therapeutics for the treatment of various diseases. Vaccinex collaborates with strategic partners and pharmaceutical companies to advance the clinical development and commercialization of its product candidates.
More about Vaccinex Inc 's Market Share
|
Gilead Sciences Inc
Share Performance
+0.49%
30 Days
|
Gilead Sciences Inc
Profile
Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.
More about Gilead Sciences Inc 's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-48.18%
One Year
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Amgen Inc
Share Performance
+0.67%
30 Days
|
Amgen Inc
Profile
Amgen Inc.s business model focuses on leveraging advanced biotechnology to create therapeutic products for various diseases, particularly in the fields of oncology, inflammation, and cardiovascular health. The company invests heavily in research and development to drive innovation, while also utilizing strategic partnerships and acquisitions to enhance its product pipeline. Additionally, Amgen emphasizes a strong global commercial presence to maximize the accessibility and impact of its therapeutics in the healthcare market.
More about Amgen Inc 's Market Share
|
Astrazeneca Plc
Share Performance
0.00%
Over The Past 5 Days
|
Astrazeneca Plc
Profile
AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.
More about Astrazeneca Plc's Market Share
|
Biocryst Pharmaceuticals Inc
Share Performance
+26.14%
One Year
|
Biocryst Pharmaceuticals Inc
Profile
Biocryst Pharmaceuticals Inc is a biotechnology company that focuses on the discovery and development of small-molecule drugs for rare diseases. They leverage their expertise in protein crystallography and drug design to create innovative therapies targeting specific proteins associated with certain diseases. Biocryst aims to bring these treatments to market by partnering with pharmaceutical companies or pursuing commercialization independently.
More about Biocryst Pharmaceuticals Inc 's Market Share
|
Mirati Therapeutics Inc
Share Performance
-0.47%
Over The Past 5 Days
|
Mirati Therapeutics Inc
Profile
Mirati Therapeutics Inc is a biotechnology company that focuses on the research, discovery, and development of precision oncology treatments for patients with cancer. Their business model involves leveraging their proprietary drug discovery platform to identify and develop targeted therapies, and collaborating with partners for the commercialization of their products.
More about Mirati Therapeutics Inc 's Market Share
|
Abbvie Inc
Share Performance
+12.98%
One Year
|
Abbvie Inc
Profile
AbbVie Inc operates primarily as a global biopharmaceutical company, focusing on the research, development, manufacturing, and commercialization of advanced therapies and medications in critical areas such as immunology, oncology, neuroscience, and virology. The company aims to improve patient outcomes and address unmet medical needs by leveraging its scientific expertise and capabilities while providing value to stakeholders in the healthcare industry.
More about Abbvie Inc 's Market Share
|
Lyra Therapeutics Inc
Share Performance
0.00%
Over The Past 5 Days
|
Lyra Therapeutics Inc
Profile
Lyra Therapeutics Inc is a biotechnology company that focuses on developing drug-delivery systems for patients with ear, nose, and throat (ENT) diseases. They utilize their proprietary technology, known as XTreo, to precisely deliver therapeutics to targeted areas within the ENT region. Their business model revolves around developing and commercializing these unique drug-delivery solutions to address unmet medical needs in the ENT field.
More about Lyra Therapeutics Inc 's Market Share
|
Merus N v
Share Performance
+0.92%
30 Days
|
Merus N v
Profile
Merus N V is a biotechnology company that operates using a differentiated and competitive business model. Their approach involves strategically targeting and developing bispecific antibodies to treat various types of cancer, leveraging their proprietary technologies and expertise in the field. By focusing on innovative research, efficient drug discovery, and partnerships, they aim to improve patient outcomes and drive growth in the oncology market.
More about Merus N v 's Market Share
|
Adagene Inc
Share Performance
+21.25%
This Quarter
|
Adagene Inc
Profile
Adagene Inc is a biotechnology company that develops novel antibody therapeutics for cancer treatment by leveraging its proprietary Dynamic Precision Library platform. Their business model involves partnering with pharmaceutical companies for the development and commercialization of their products.
More about Adagene Inc 's Market Share
|
Adc Therapeutics Sa
Share Performance
+172.73%
This Quarter
|
Adc Therapeutics Sa
Profile
Adc Therapeutics Sa is a biotechnology company that focuses on the development and commercialization of antibody drug conjugates (ADCs) for the treatment of cancer. Their business model revolves around using their proprietary pyrrolobenzodiazepine (PBD) technology to create highly potent ADCs that selectively target cancer cells while minimizing damage to healthy cells. They aim to collaborate with global pharmaceutical companies to co-develop and potentially commercialize their ADC candidates, generating revenue through licensing agreements and milestone payments.
More about Adc Therapeutics Sa's Market Share
|
Affimed N v
Share Performance
0.00%
30 Days
|
Affimed N v
Profile
Affimed N is a biopharmaceutical company that operates through a partnership-based business model, collaborating with leaders in the healthcare industry and utilizing its proprietary technology platform to develop novel cancer immunotherapies. By leveraging these collaborations and its innovative platform, Affimed N aims to advance the development of effective treatments for cancer.
More about Affimed N v 's Market Share
|
Alx Oncology Holdings Inc
Share Performance
-3.01%
30 Days
|
Alx Oncology Holdings Inc
Profile
Alx Oncology Holdings Inc's business model is centered around the development and commercialization of innovative cancer therapeutics.
More about Alx Oncology Holdings Inc's Market Share
|
Aravive Inc
Share Performance
-68.96%
This Year
|
Aravive Inc
Profile
Aravive Inc operates on a business model that focuses on developing and commercializing innovative therapies to treat life-threatening diseases by targeting key signaling pathways.
More about Aravive Inc 's Market Share
|
Atossa Therapeutics Inc
Share Performance
+6.91%
30 Days
|
Atossa Therapeutics Inc
Profile
Atossa Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for breast conditions and oncology.
More about Atossa Therapeutics Inc 's Market Share
|
Biomea Fusion Inc
Share Performance
-47.70%
This Year
|
Biomea Fusion Inc
Profile
Biomea Fusion Inc operates on a business model focused on the development of precision medicine for cancer treatments. They leverage advanced genomic technologies to identify and understand specific gene fusions that drive cancer growth. By developing targeted therapies, they aim to improve patient outcomes and revolutionize cancer treatment.
More about Biomea Fusion Inc 's Market Share
|
Bristol myers Squibb Company
Share Performance
+1.97%
Over The Past 5 Days
|
Bristol myers Squibb Company
Profile
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
More about Bristol myers Squibb Company's Market Share
|
Bolt Biotherapeutics Inc
Share Performance
-57.24%
One Year
|
Bolt Biotherapeutics Inc
Profile
Bolt Biotherapeutics Inc's business model focuses on developing novel immunotherapies for the treatment of cancer.
More about Bolt Biotherapeutics Inc 's Market Share
|
Blueprint Medicines Corporation
Share Performance
+1.07%
30 Days
|
Blueprint Medicines Corporation
Profile
The business model of Blueprint Medicines Corporation revolves around the development and commercialization of precision therapies for patients with genomically defined cancers and rare diseases. They actively pursue a strategy of genomically targeted drug discovery and development, utilizing advanced technologies and clinical expertise to bring potentially life-changing treatments to market. The company focuses on creating value through strategic collaborations, licensing agreements, and the commercialization of their innovative therapies.
More about Blueprint Medicines Corporation's Market Share
|
Checkpoint Therapeutics inc
Share Performance
+57.20%
This Quarter
|
Checkpoint Therapeutics inc
Profile
Checkpoint Therapeutics Inc is a biopharmaceutical company that develops and commercializes immune-targeted therapies for the treatment of cancer. The company mainly focuses on acquiring, developing, and commercializing targeted immunotherapy and immuno-oncology products. Through collaborations and strategic partnerships, Checkpoint Therapeutics aims to bring innovative and effective therapies to patients while creating value for shareholders.
More about Checkpoint Therapeutics inc 's Market Share
|
Cogent Biosciences Inc
Share Performance
+39.10%
This Year
|
Cogent Biosciences Inc
Profile
Cogent Biosciences Inc operates on a biopharmaceutical business model focused on the development and commercialization of precision therapies for patients with genetically driven diseases. The company utilizes its proprietary expertise in discovering, designing, and developing therapies to target specific genetic alterations with the aim of improving patient outcomes and quality of life. By leveraging their scientific knowledge and strategic partnerships, Cogent Biosciences Inc aims to advance precision medicine and address unmet medical needs in the field of genetic diseases.
More about Cogent Biosciences Inc 's Market Share
|
Cytomx Therapeutics Inc
Share Performance
+145.28%
This Year
|
Cytomx Therapeutics Inc
Profile
Cytomx Therapeutics Inc is a biopharmaceutical company that focuses on developing novel antibody-based therapeutics for the treatment of cancer. They utilize proprietary Probody technology to create highly specific and targeted therapies that have the potential to improve treatment outcomes for patients with cancer.
More about Cytomx Therapeutics Inc 's Market Share
|
Cytodyn inc
Share Performance
+128.76%
One Year
|
Cytodyn inc
Profile
Cytodyn Inc is a biotechnology company that focuses on the development and commercialization of innovative treatments for a range of diseases, including cancer and viral infections. The company primarily generates revenue through the licensing and sale of its therapeutics to medical institutions and pharmaceutical companies. Cytodyn's business model revolves around the research and development of novel drugs, conducting clinical trials, and forming strategic partnerships to bring their innovative treatments to market.
More about Cytodyn inc 's Market Share
|
Day One Biopharmaceuticals Inc
Share Performance
0.00%
Over The Past 5 Days
|
Day One Biopharmaceuticals Inc
Profile
Day One Biopharmaceuticals Inc operates with a business model focused on developing targeted therapies for patients with rare genetic diseases and cancer. They aim to leverage their expertise in precision medicine and drug discovery to create innovative treatments that address unmet medical needs. Their approach involves identifying genetic mutations and developing therapies tailored specifically to target these mutations and improve patient outcomes.
More about Day One Biopharmaceuticals Inc 's Market Share
|
Deciphera Pharmaceuticals Inc
Share Performance
+0.87%
30 Days
|
Deciphera Pharmaceuticals Inc
Profile
Deciphera Pharmaceuticals Inc's business model revolves around the research, development, and commercialization of precision medicines for the treatment of cancer and other serious diseases.
More about Deciphera Pharmaceuticals Inc 's Market Share
|
Effector Therapeutics Inc
Share Performance
-99.98%
One Year
|
Effector Therapeutics Inc
Profile
Effector Therapeutics Inc is a biotech company focused on developing and commercializing effective cancer treatments.
More about Effector Therapeutics Inc 's Market Share
|
Essa Pharma inc
Share Performance
+7.36%
This Quarter
|
Essa Pharma inc
Profile
Essa Pharma Inc.'s business model revolves around the development of targeted small molecule therapeutics for the treatment of cancer. The company aims to address the unmet medical needs of patients with advanced and metastatic forms of prostate and breast cancer. By leveraging their expertise in clinical development and precision medicine, Essa Pharma aspires to bring innovative and effective treatments to market, ultimately improving patient outcomes.
More about Essa Pharma inc 's Market Share
|
Erasca Inc
Share Performance
-43.70%
This Year
|
Erasca Inc
Profile
Erasca Inc is a biotechnology company that focuses on discovering and developing innovative therapies for cancer. Their business model revolves around leveraging cutting-edge technologies and scientific expertise to identify and advance multiple drug candidates simultaneously. By collaborating with academic institutions and biopharmaceutical partners, Erasca aims to accelerate the development of cancer treatments to improve patient outcomes.
More about Erasca Inc 's Market Share
|
Genprex Inc
Share Performance
0.00%
Over The Past 5 Days
|
Genprex Inc
Profile
Genprex Inc's business model focuses on the development and commercialization of gene therapies for the treatment of cancer.
More about Genprex Inc 's Market Share
|
Gossamer Bio Inc
Share Performance
+63.86%
This Quarter
|
Gossamer Bio Inc
Profile
Gossamer Bio Inc operates with a business model focused on the development and commercialization of novel therapies for patients with complex diseases. They leverage extensive scientific expertise and strategic partnerships to identify and advance a diverse pipeline of innovative medicines. Their goal is to deliver transformative therapies that address significant unmet medical needs and improve patient outcomes.
More about Gossamer Bio Inc 's Market Share
|
G1 Therapeutics Inc
Share Performance
+0.28%
Over The Past 5 Days
|
G1 Therapeutics Inc
Profile
G1 Therapeutics Inc is a biopharmaceutical company that operates under a research and development business model. They focus on discovering, developing, and commercializing novel therapies to address unmet needs in cancer treatment, with a strong emphasis on targeting specific cellular processes. Their business model involves conducting preclinical and clinical trials, obtaining regulatory approvals, and collaborating with strategic partners to bring their innovative drugs to market.
More about G1 Therapeutics Inc 's Market Share
|
Werewolf Therapeutics Inc
Share Performance
-11.48%
30 Days
|
Werewolf Therapeutics Inc
Profile
Werewolf Therapeutics Inc operates with a business model focused on utilizing innovative technologies to develop therapies targeting cancer using immune cell activation.
More about Werewolf Therapeutics Inc 's Market Share
|
Ideaya Biosciences Inc
Share Performance
+34.28%
This Quarter
|
Ideaya Biosciences Inc
Profile
Ideaya Biosciences Inc operates on a precision medicine approach that combines genomics and synthetic lethality to develop targeted cancer therapies. The company focuses on identifying synthetic lethal interactions in cancer and leveraging these insights to discover and develop drugs that selectively target cancer cells. They collaborate with academic institutions and industry partners to advance their therapeutic pipeline and bring innovative treatments to patients in need.
More about Ideaya Biosciences Inc 's Market Share
|
I mab
Share Performance
+29.75%
One Year
|
I mab
Profile
The I Mab business model focuses on the development and commercialization of innovative biopharmaceutical products. They specialize in the research and development of novel antibodies and other therapeutic agents to address unmet medical needs. By collaborating with strategic partners and leveraging their expertise in drug discovery and clinical development, I Mab aims to bring transformative treatments to patients globally.
More about I mab's Market Share
|
Immunogen inc
Share Performance
+5.29%
This Year
|
Immunogen inc
Profile
Immunogen Inc is a biotechnology company that focuses on the development of antibody-drug conjugates (ADCs) for the treatment of various types of cancer. Their business model is centered around leveraging their proprietary technology platform to create ADCs that deliver potent cancer-killing agents directly to tumor cells. By partnering with pharmaceutical companies, Immunogen aims to advance their ADC candidates through clinical trials and ultimately bring them to market, aiming to improve the lives of cancer patients.
More about Immunogen inc 's Market Share
|
Immuneering Corporation
Share Performance
+235.66%
This Quarter
|
Immuneering Corporation
Profile
Immuneering Corp operates on a business model that harnesses the power of big data in the field of biomedicine. Through their proprietary technologies, they analyze vast amounts of biological data to gain insights into disease mechanisms, drug discovery, and patient care. They leverage their expertise to provide pharmaceutical companies and healthcare organizations with actionable information for accelerating the development of new therapeutics and improving clinical outcomes.
More about Immuneering Corporation's Market Share
|
Janux Therapeutics Inc
Share Performance
-11.87%
This Quarter
|
Janux Therapeutics Inc
Profile
Janux Therapeutics Inc is a biotechnology company that focuses on developing and commercializing innovative cancer treatments. Their business model revolves around leveraging their expertise in immunotherapies and bispecific antibody platforms to create novel therapies that target tumor cells and activate the patient's immune system. By partnering with pharmaceutical companies and conducting clinical trials, they aim to bring effective and personalized cancer treatments to market.
More about Janux Therapeutics Inc 's Market Share
|
Kinnate Biopharma Inc
Share Performance
+0.76%
Over The Past 5 Days
|
Kinnate Biopharma Inc
Profile
Kinnate Biopharma Inc is a company that focuses on developing targeted therapies for genetically-defined cancers.
More about Kinnate Biopharma Inc 's Market Share
|
Kura Oncology Inc
Share Performance
-71.03%
One Year
|
Kura Oncology Inc
Profile
Kura Oncology Inc is a biotechnology company that focuses on the discovery and development of precision medicines for the treatment of cancer. Their business model revolves around leveraging their expertise in oncology to identify and design small molecule drug candidates that target specific genetic mutations or biomarkers. Through strategic partnerships and collaborations, Kura aims to advance their drug candidates through clinical studies and ultimately commercialize these precision medicines for patients in need.
More about Kura Oncology Inc 's Market Share
|
Eli Lilly And Company
Share Performance
+2.44%
Over The Past 5 Days
|
Eli Lilly And Company
Profile
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
More about Eli Lilly And Company's Market Share
|
Lantern Pharma Inc
Share Performance
+15.08%
30 Days
|
Lantern Pharma Inc
Profile
Lantern Pharma Inc's business model focuses on leveraging artificial intelligence and machine learning to identify and repurpose existing drugs for the treatment of various diseases.
More about Lantern Pharma Inc 's Market Share
|
Macrogenics Inc
Share Performance
-66.02%
One Year
|
Macrogenics Inc
Profile
Macrogenics Inc is a biopharmaceutical company that focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer and autoimmune diseases.
More about Macrogenics Inc 's Market Share
|
Mural Oncology Plc
Share Performance
+3.11%
This Quarter
|
Mural Oncology Plc
Profile
Mural Oncology Plc's business model focuses on developing and commercializing innovative cancer therapies. They likely collaborate with research institutes and pharmaceutical companies to acquire promising drug candidates and conduct rigorous clinical trials. Their revenue is generated through licensing, partnerships, and potential product sales, helping provide solutions for patients suffering from various forms of cancer.
More about Mural Oncology Plc's Market Share
|
Nucana Plc
Share Performance
-95.19%
This Year
|
Nucana Plc
Profile
Nucana Plc is a pharmaceutical company that focuses on developing novel treatments for cancer and other diseases.
More about Nucana Plc's Market Share
|
Nuvalent Inc
Share Performance
+15.95%
This Quarter
|
Nuvalent Inc
Profile
Nuvalent Inc's business model entails developing innovative pharmaceutical solutions utilizing its proprietary technology and expertise.
More about Nuvalent Inc 's Market Share
|
Novartis Ag
Share Performance
+11.97%
One Year
|
Novartis Ag
Profile
Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.
More about Novartis Ag's Market Share
|
Northwest Biotherapeutics Inc
Share Performance
-18.01%
This Year
|
Northwest Biotherapeutics Inc
Profile
Northwest Biotherapeutics Inc's business model focuses on the development and commercialization of personalized immunotherapy products for the treatment of cancer.
More about Northwest Biotherapeutics Inc's Market Share
|
Nextcure Inc
Share Performance
-42.90%
This Year
|
Nextcure Inc
Profile
NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need.
More about Nextcure Inc 's Market Share
|
Olema Pharmaceuticals Inc
Share Performance
0.00%
Over The Past 5 Days
|
Olema Pharmaceuticals Inc
Profile
Olema Pharmaceuticals Inc.'s business model focuses on the research, development, and commercialization of innovative cancer therapies.
More about Olema Pharmaceuticals Inc 's Market Share
|
Oncosec Medical Incorporated
Share Performance
-45.66%
30 Days
|
Oncosec Medical Incorporated
Profile
Oncosec Medical Incorporated's business model revolves around developing and commercializing innovative immunotherapies for the treatment of various cancers.
More about Oncosec Medical Incorporated's Market Share
|
Oncternal Therapeutics Inc
Share Performance
-82.95%
This Quarter
|
Oncternal Therapeutics Inc
Profile
Oncternal Therapeutics Inc's business model focuses on developing and commercializing novel therapies for the treatment of cancer.
More about Oncternal Therapeutics Inc 's Market Share
|
Oric Pharmaceuticals Inc
Share Performance
+18.90%
30 Days
|
Oric Pharmaceuticals Inc
Profile
Oric Pharmaceuticals Inc's business model focuses on the development and commercialization of innovative therapeutics for the treatment of cancer.
More about Oric Pharmaceuticals Inc 's Market Share
|
Panbela Therapeutics Inc
Share Performance
-39.89%
This Year
|
Panbela Therapeutics Inc
Profile
Panbela Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative and effective treatments for pancreatic cancer. They aim to leverage their expertise in drug development and strategic partnerships to bring novel therapies to the market and address the unmet medical needs of patients with this devastating disease.
More about Panbela Therapeutics Inc 's Market Share
|
Pfizer Inc
Share Performance
-11.57%
One Year
|
Pfizer Inc
Profile
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
More about Pfizer Inc's Market Share
|
Protagonist Therapeutics inc
Share Performance
+12.51%
This Quarter
|
Protagonist Therapeutics inc
Profile
Protagonist Therapeutics Inc's business model focuses on the development and commercialization of novel peptide-based therapeutics.
More about Protagonist Therapeutics inc 's Market Share
|
Rain Oncology Inc
Share Performance
-52.19%
This Year
|
Rain Oncology Inc
Profile
Rain Therapeutics Inc is a biopharmaceutical company that focuses on discovering and developing precision oncology therapies. Their business model revolves around identifying genetic alterations and biomarkers in cancer patients, and then developing targeted therapies to address these specific alterations. By tailoring treatments to individual patients, they aim to improve outcomes and provide more effective and personalized cancer care.
More about Rain Oncology Inc 's Market Share
|
Rapt Therapeutics Inc
Share Performance
+428.83%
This Year
|
Rapt Therapeutics Inc
Profile
Rapt Therapeutics Inc operates based on a business model that focuses on developing and commercializing transformative oral small molecules, known as immunomodulators. Their compounds target specific immune cell subsets within the body to provide potential therapeutic benefits in various diseases. By leveraging their expertise in immunology and small molecule drug design, Rapt strives to deliver innovative treatment options to patients in need.
More about Rapt Therapeutics Inc 's Market Share
|
Repare Therapeutics Inc
Share Performance
+18.18%
This Year
|
Repare Therapeutics Inc
Profile
Repare Therapeutics Inc is a biotechnology company that specializes in the development of precision oncology drugs. Their business model focuses on leveraging synthetic lethality, a targeted therapy approach, to identify and develop small molecule drugs for the treatment of various forms of cancer. By discovering and advancing novel therapeutics, Repare Therapeutics aims to improve patient outcomes and address unmet medical needs in oncology.
More about Repare Therapeutics Inc 's Market Share
|
Sagimet Biosciences inc
Share Performance
+203.06%
One Year
|
Sagimet Biosciences inc
Profile
Sagimet Biosciences Inc is a biopharmaceutical company that operates on a research-based business model focused on developing therapeutic solutions for metabolic diseases. They employ a multidisciplinary approach that combines scientific research, preclinical assessments, and clinical trials to advance their drug candidates. Sagimet Biosciences aims to bring effective treatments to patients by leveraging their expertise in metabolic disease biology and collaborating with key stakeholders in the medical community.
More about Sagimet Biosciences inc 's Market Share
|
Syndax Pharmaceuticals Inc
Share Performance
0.00%
Over The Past 5 Days
|
Syndax Pharmaceuticals Inc
Profile
Syndax Pharmaceuticals Inc has a business model centered around developing innovative cancer treatments. They focus on leveraging their expertise in epigenetics and immuno-oncology to create therapies that target specific cancer types. Syndax collaborates with strategic partners and utilizes clinical trials to bring their treatments to market and improve patient outcomes.
More about Syndax Pharmaceuticals Inc 's Market Share
|
Shattuck Labs Inc
Share Performance
-36.01%
This Year
|
Shattuck Labs Inc
Profile
Shattuck Labs Inc operates through a platform-based business model, focusing on the development of biotechnology products and solutions. By utilizing its proprietary technology and expertise, the company aims to create innovative therapies targeting various diseases and disorders, ultimately improving patient outcomes. Shattuck Labs Inc collaborates with strategic partners and stakeholders to advance its pipeline, aiming to commercialize its novel treatments and drive growth in the biotech industry.
More about Shattuck Labs Inc 's Market Share
|
Syros Pharmaceuticals Inc
Share Performance
-99.85%
One Year
|
Syros Pharmaceuticals Inc
Profile
Syros Pharmaceuticals Inc operates based on a business model focused on developing targeted gene control therapies to treat various diseases. The company aims to leverage its gene control platform to identify and exploit unique gene regulatory networks to discover and develop novel therapeutics.
More about Syros Pharmaceuticals Inc 's Market Share
|
Tg Therapeutics Inc
Share Performance
+4.61%
30 Days
|
Tg Therapeutics Inc
Profile
TG Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for patients with hematological malignancies and autoimmune diseases.
More about Tg Therapeutics Inc 's Market Share
|
Theseus Pharmaceuticals Inc
Share Performance
+83.71%
This Quarter
|
Theseus Pharmaceuticals Inc
Profile
Theseus Pharmaceuticals Inc operates on a business model focused on the development and commercialization of pharmaceutical products.
More about Theseus Pharmaceuticals Inc 's Market Share
|
Tyme Technologies Inc.
Share Performance
-69.83%
One Year
|
Tyme Technologies Inc.
Profile
Tyme Technologies Inc. is a biotechnology company that operates through the development and commercialization of pharmaceutical products. Their business model focuses on the research, development, and sale of proprietary cancer therapy drug candidates. By leveraging innovative technology and strategic partnerships, Tyme aims to bring novel treatment options to the market, improving patient outcomes and addressing unmet medical needs in the oncology field.
More about Tyme Technologies Inc.'s Market Share
|
Verastem Inc
Share Performance
-26.96%
This Year
|
Verastem Inc
Profile
Verastem Inc is a biopharmaceutical company that focuses on discovering and developing medicines to treat cancer by targeting the underlying biology of the disease. They employ a research-driven business model to identify novel therapeutic candidates, evaluate their potential through preclinical and clinical trials, and bring them to market with the goal of improving patient outcomes. Verastem emphasizes innovation, precision medicine, and strategic collaborations to advance their pipeline of cancer therapeutics.
More about Verastem Inc 's Market Share
|
Xencor Inc
Share Performance
+0.98%
30 Days
|
Xencor Inc
Profile
Xencor Inc is a biotechnology company that primarily focuses on the development of therapeutic antibodies. Their business model revolves around utilizing their proprietary XmAb? technology to engineer antibodies with enhanced properties for the treatment of various diseases. They collaborate with pharmaceutical companies to develop and commercialize these antibody therapeutics, generating revenue through upfront payments, milestone payments, and royalties.
More about Xencor Inc's Market Share
|
Zai Lab Limited
Share Performance
+12.18%
This Quarter
|
Zai Lab Limited
Profile
Zai Lab Limited operates as a biopharmaceutical company primarily in China. The company seeks to discover, develop, and commercialize innovative medicines to address unmet medical needs in the country. Zai Lab focuses on licensing and acquiring clinical stage or late-stage development drugs, and then progressing them through regulatory approval and commercial launch.
More about Zai Lab Limited's Market Share
|
Zentalis Pharmaceuticals Inc
Share Performance
-54.33%
This Year
|
Zentalis Pharmaceuticals Inc
Profile
Zentalis Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of small molecule therapies for the treatment of various types of cancer. Their business model revolves around leveraging their expertise in drug discovery, conducting clinical trials, and ultimately commercializing effective cancer treatments. By leveraging their innovative research and development capabilities, Zentalis aims to address unmet medical needs and improve the lives of cancer patients worldwide.
More about Zentalis Pharmaceuticals Inc 's Market Share
|
Nektar Therapeutics
Share Performance
+162.40%
This Quarter
|
Nektar Therapeutics
Profile
Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs.
More about Nektar Therapeutics's Market Share
|
Mannkind Corporation
Share Performance
0.00%
Over The Past 5 Days
|
Mannkind Corporation
Profile
MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic solutions for patients with diseases such as diabetes and pulmonary arterial hypertension. The company's business model revolves around conducting research and development to create innovative inhalation therapies and gaining regulatory approvals for these treatments. They then market and distribute their products, either directly or through partnerships, to healthcare providers and patients worldwide.
More about Mannkind Corporation's Market Share
|
Arvinas Inc
Share Performance
+6.77%
30 Days
|
Arvinas Inc
Profile
Arvinas Inc's business model revolves around developing novel therapies based on protein degradation technology to address unmet medical needs.
More about Arvinas Inc 's Market Share
|
Revance Therapeutics Inc
Share Performance
+7.67%
30 Days
|
Revance Therapeutics Inc
Profile
Revance Therapeutics Inc is a biotechnology company that specializes in developing innovative treatments for medical aesthetic and therapeutic applications. Their business model revolves around researching and developing novel neuromodulator products primarily for the treatment of various aesthetic and therapeutic conditions. The company aims to license or commercialize their products and technologies to generate revenue and advance patient care in collaboration with partners.
More about Revance Therapeutics Inc 's Market Share
|
Evolus Inc
Share Performance
-4.89%
This Quarter
|
Evolus Inc
Profile
Evolus Inc is a pharmaceutical company that operates in the field of aesthetics, with a primary focus on developing and commercializing minimally invasive treatments for patients. Their business model revolves around researching and developing innovative neurotoxin products to address various facial aesthetic concerns. The company aims to bring their products to market through strategic partnerships with healthcare professionals and providers, ensuring widespread accessibility and utilization.
More about Evolus Inc 's Market Share
|
Morphosys Ag
Share Performance
+147.52%
One Year
|
Morphosys Ag
Profile
Morphosys Ag's business model revolves around the development and commercialization of therapeutic antibodies.
More about Morphosys Ag's Market Share
|
Travere Therapeutics Inc
Share Performance
+14.14%
30 Days
|
Travere Therapeutics Inc
Profile
Travere Therapeutics Inc operates under a business model focused on developing and commercializing therapies for rare diseases. They aim to provide innovative treatments and solutions for patients suffering from these conditions. The company primarily focuses on research, development, and distribution of pharmaceutical products tailored for rare diseases.
More about Travere Therapeutics Inc 's Market Share
|
Puma Biotechnology Inc
Share Performance
+2.33%
One Year
|
Puma Biotechnology Inc
Profile
Puma Biotechnology Inc operates as a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Their business model revolves around identifying promising preclinical and clinical drug candidates, conducting rigorous research and development, and seeking regulatory approval for their products. Puma Biotechnology Inc strives to effectively market and distribute their approved therapeutics to provide patients with potentially life-saving treatment options.
More about Puma Biotechnology Inc 's Market Share
|
Atea Pharmaceuticals Inc
Share Performance
+10.53%
This Year
|
Atea Pharmaceuticals Inc
Profile
Atea Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing antiviral therapeutics to combat infectious diseases. Their business model revolves around identifying and advancing novel drug candidates that target specific viral mechanisms and inhibit their replication. This includes conducting preclinical and clinical trials, engaging in strategic partnerships, and ultimately bringing effective antiviral treatments to market.
More about Atea Pharmaceuticals Inc 's Market Share
|
Myovant Sciences Ltd
Share Performance
+0.11%
Over The Past 5 Days
|
Myovant Sciences Ltd
Profile
Myovant Sciences Ltd operates under a biopharmaceutical business model primarily focused on the development and commercialization of therapies for women's health and prostate cancer. The company aims to leverage its expertise in clinical research, regulatory affairs, and manufacturing to bring innovative treatments to market and improve patients' lives. Myovant Sciences employs a combination of in-house research and development along with collaboration with strategic partners to advance its pipeline of product candidates.
More about Myovant Sciences Ltd 's Market Share
|
Chimerix Inc
Share Performance
+829.25%
One Year
|
Chimerix Inc
Profile
Chimerix Inc is a pharmaceutical company that focuses on developing antiviral therapeutics for various diseases. Their business model revolves around conducting research and development to create innovative drug candidates, seeking partnerships and collaborations with other companies to advance their products, and ultimately gaining regulatory approval and commercializing their drugs in the market. By strategically targeting unmet medical needs and leveraging their expertise, Chimerix aims to improve patient outcomes and generate revenue through the successful development and distribution of their antiviral therapeutics.
More about Chimerix Inc 's Market Share
|
Medicinova Inc
Share Performance
0.00%
Over The Past 5 Days
|
Medicinova Inc
Profile
Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes.
More about Medicinova Inc 's Market Share
|
Xilio Therapeutics inc
Share Performance
0.00%
Over The Past 5 Days
|
Xilio Therapeutics inc
Profile
Xilio Therapeutics Inc is a biotechnology company focused on developing and commercializing novel immunotherapies to treat cancer.
More about Xilio Therapeutics inc 's Market Share
|
Prelude Therapeutics Inc
Share Performance
-29.03%
This Year
|
Prelude Therapeutics Inc
Profile
Prelude Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative small molecule therapeutic products for cancer treatment. Their business model revolves around conducting extensive research and employing a target discovery engine to identify and validate potential drug targets. By using a combination of proprietary technologies and collaborations with academic institutions, Prelude Therapeutics aims to develop and commercialize novel oncology therapies to address unmet medical needs.
More about Prelude Therapeutics Inc's Market Share
|
Eqrx Inc
Share Performance
+4.46%
This Quarter
|
Eqrx Inc
Profile
Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.
More about Eqrx Inc 's Market Share
|
Therapeuticsmd Inc
Share Performance
-32.58%
One Year
|
Therapeuticsmd Inc
Profile
TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.
More about Therapeuticsmd Inc's Market Share
|
Legend Biotech Corporation
Share Performance
+17.69%
This Quarter
|
Legend Biotech Corporation
Profile
Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases.
More about Legend Biotech Corporation's Market Share
|
Organon and Co
Share Performance
-53.78%
One Year
|
Organon and Co
Profile
Organon and Co's business model revolves around developing and manufacturing pharmaceutical products.
More about Organon and Co 's Market Share
|
Teva Pharmaceutical Industries Limited
Share Performance
+21.54%
This Quarter
|
Teva Pharmaceutical Industries Limited
Profile
Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.
More about Teva Pharmaceutical Industries Limited's Market Share
|
Viatris Inc
Share Performance
+23.66%
This Quarter
|
Viatris Inc
Profile
Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.
More about Viatris Inc 's Market Share
|
Sanofi
Share Performance
-2.49%
This Quarter
|
Sanofi
Profile
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
More about Sanofi's Market Share
|
Innovation Pharmaceuticals Inc
Share Performance
0.00%
30 Days
|
Innovation Pharmaceuticals Inc
Profile
Innovation Pharmaceuticals Inc operates under a business model focused on pharmaceutical research and development. They strive to innovate and discover novel drug candidates to address unmet medical needs. Through collaborations, partnerships, and internal capabilities, they aim to bring potential therapies through clinical trials and eventually to market.
More about Innovation Pharmaceuticals Inc 's Market Share
|
Tonix Pharmaceuticals Holding Corp
Share Performance
0.00%
Over The Past 5 Days
|
Tonix Pharmaceuticals Holding Corp
Profile
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing and commercializing innovative therapies for psychiatric and neurological conditions. Their business model revolves around identifying potential drug candidates, conducting preclinical and clinical trials to evaluate their efficacy and safety, and ultimately obtaining regulatory approval for their products to bring them to market. Through strategic partnerships and collaborations, they aim to commercialize and distribute their therapies to provide much-needed treatment options for patients.
More about Tonix Pharmaceuticals Holding Corp 's Market Share
|
Allarity Therapeutics Inc
Share Performance
-81.95%
One Year
|
Allarity Therapeutics Inc
Profile
Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.
More about Allarity Therapeutics Inc 's Market Share
|
Viracta Therapeutics Inc
Share Performance
0.00%
Over The Past 5 Days
|
Viracta Therapeutics Inc
Profile
Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.
More about Viracta Therapeutics Inc 's Market Share
|
Biophytis Sa
Share Performance
-25.59%
Over The Past 5 Days
|
Biophytis Sa
Profile
Biophytis SA is a biotechnology company that focuses on developing innovative therapeutics for age-related diseases, with a specific emphasis on degenerative eye diseases and muscle wasting conditions. They leverage their expertise in biology and clinical development to discover and advance targeted drug candidates, aiming to address the unmet medical needs of patients in these areas.
More about Biophytis Sa's Market Share
|
Cadrenal Therapeutics Inc
Share Performance
0.00%
Over The Past 5 Days
|
Cadrenal Therapeutics Inc
Profile
Cadrenal Therapeutics Inc's business model revolves around the development and commercialization of innovative therapies in the field of renal diseases.
More about Cadrenal Therapeutics Inc's Market Share
|
Nanoviricides inc
Share Performance
-0.70%
This Year
|
Nanoviricides inc
Profile
Nanoviricides Inc. is a pharmaceutical company that operates on a business model based on the development and commercialization of nanomedicines.
More about Nanoviricides inc 's Market Share
|
Cns Pharmaceuticals Inc
Share Performance
-98.56%
One Year
|
Cns Pharmaceuticals Inc
Profile
CNS Pharmaceuticals Inc's business model focuses on developing innovative solutions and treatments for central nervous system diseases.
More about Cns Pharmaceuticals Inc 's Market Share
|
Abvc Biopharma Inc
Share Performance
+272.22%
This Quarter
|
Abvc Biopharma Inc
Profile
ABVC Biopharma Inc is a pharmaceutical company that focuses on the development and commercialization of innovative biopharmaceutical products.
More about Abvc Biopharma Inc's Market Share
|
Immuron Limited
Share Performance
-0.61%
This Year
|
Immuron Limited
Profile
Immuron Limited's business model involves the development and commercialization of oral immunotherapeutics that target and treat various diseases.
More about Immuron Limited's Market Share
|
Iterum Therapeutics Plc
Share Performance
-3.57%
This Quarter
|
Iterum Therapeutics Plc
Profile
Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.
More about Iterum Therapeutics Plc's Market Share
|
Esperion Therapeutics Inc
Share Performance
+24.54%
This Quarter
|
Esperion Therapeutics Inc
Profile
Esperion Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for addressing cardiovascular diseases.
More about Esperion Therapeutics Inc 's Market Share
|
Cellectar Biosciences Inc
Share Performance
-48.65%
This Year
|
Cellectar Biosciences Inc
Profile
Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.
More about Cellectar Biosciences Inc 's Market Share
|
Journey Medical Corp
Share Performance
+27.11%
One Year
|
Journey Medical Corp
Profile
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
More about Journey Medical Corp's Market Share
|
Abeona Therapeutics Inc
Share Performance
-1.02%
This Year
|
Abeona Therapeutics Inc
Profile
Abeona Therapeutics Inc is a biopharmaceutical company focused on developing gene and cell therapies for rare genetic diseases. Their business model revolves around identifying and acquiring promising technologies, conducting pre-clinical and clinical research, and eventually bringing these therapies to the market. They collaborate with academic institutions, medical centers, and patient advocacy groups to advance their pipeline and provide solutions for currently untreatable genetic disorders.
More about Abeona Therapeutics Inc 's Market Share
|
Casi Pharmaceuticals inc
Share Performance
-77.52%
One Year
|
Casi Pharmaceuticals inc
Profile
Casi Pharmaceuticals Inc. operates under a business model that focuses on the development and commercialization of innovative pharmaceutical products. They likely employ a combination of in-house research and development, partnerships, and licensing agreements to bring their products to market. The company may also engage in strategic marketing and distribution partnerships to ensure the successful commercialization of their therapeutics.
More about Casi Pharmaceuticals inc 's Market Share
|
Mineralys Therapeutics Inc
Share Performance
+5.48%
This Quarter
|
Mineralys Therapeutics Inc
Profile
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
More about Mineralys Therapeutics Inc 's Market Share
|
Takeda Pharmaceutical Company Limited
Share Performance
+2.06%
This Quarter
|
Takeda Pharmaceutical Company Limited
Profile
Takeda Pharmaceutical Company Limited operates under a business model that primarily focuses on research, development, and commercialization of innovative pharmaceutical products. They collaborate with various stakeholders across the healthcare industry, including academia, biotechnology companies, and patient advocacy groups, to drive scientific advancements and understand patient needs. By leveraging their expertise, global presence, and strategic partnerships, Takeda aims to make a positive impact on patients' lives while ensuring long-term growth and sustainability.
More about Takeda Pharmaceutical Company Limited's Market Share
|
Johnson and Johnson
Share Performance
+0.59%
30 Days
|
Johnson and Johnson
Profile
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
More about Johnson and Johnson's Market Share
|
Merck and Co Inc
Share Performance
-16.08%
This Year
|
Merck and Co Inc
Profile
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
More about Merck and Co Inc 's Market Share
|
Sources: Allakos Inc and all companies mentioned above in this report
|
